Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.santini@uniroma1.it
Daniele Santini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
daniele.santini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients
TRANSLATIONAL LUNG CANCER RESEARCH
2021
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis
EUROPEAN JOURNAL OF CANCER
2021
ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more
INTERNATIONAL IMMUNOPHARMACOLOGY
2021
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators
JOURNAL OF TRANSLATIONAL MEDICINE
2021
The screening and consensus based on practices and evidence (Scope) program–results of a survey on daily practice patterns for patients with mcrc
CURRENT ONCOLOGY
2021
Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial
JAMA ONCOLOGY
2021
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
JOURNAL OF BONE ONCOLOGY
2021
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS
2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
ONCOGENE
2021
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
JOURNAL OF GASTROINTESTINAL CANCER
2021
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms
FRONTIERS IN ONCOLOGY
2021
Response to: Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations
THORACIC CANCER
2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE
JOURNAL OF BONE ONCOLOGY
2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index
JOURNAL OF GASTROINTESTINAL CANCER
2021
Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer
CLINICAL LUNG CANCER
2021
Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
2021
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
FRONTIERS IN ONCOLOGY
2021
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines
ANNALS OF ONCOLOGY
2021
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma
BIOLOGY
2021
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
…
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma